BP
TMO icon

BBR Partners’s Thermo Fisher Scientific TMO Stock Holding History

BBR Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-557
Closed -$324K – 261
2024
Q1 		$324K Buy
+557
New +$313K 0.03% 183
2023
Q4 		– Sell
-623
Closed -$315K – 224
2023
Q3 		$315K Buy
+623
New +$332K 0.04% 140
2022
Q3 		– Sell
-995
Closed -$541K – 228
2022
Q2 		$541K Hold
995
– – 0.06% 122
2022
Q1 		$588K Sell
995
-31
-3% -$17.8K 0.06% 123
2021
Q4 		$685K Sell
1,026
-9
-0.9% -$5.62K 0.08% 100
2021
Q3 		$591K Buy
1,035
+11
+1% +$6.04K 0.05% 114
2021
Q2 		$517K Sell
1,024
-25
-2% -$11.8K 0.04% 113
2021
Q1 		$479K Sell
1,049
-647
-38% -$309K 0.04% 126
2020
Q4 		$790K Buy
1,696
+54
+3% +$25.3K 0.07% 94
2020
Q3 		$725K Buy
1,642
+762
+87% +$315K 0.06% 96
2020
Q2 		$319K Buy
+880
New +$295K 0.04% 128
2020
Q1 		– Sell
-707
Closed -$230K – 205
2019
Q4 		$230K Buy
+707
New +$214K 0.03% 175

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BBR Partners's TMO Position: Q2 2024 in Review

BBR Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 557 shares — an estimated $324K sold.

BBR Partners first reported a position in TMO in Q4 2019 and held it in 12 quarters. The position peaked at $790K in Q4 2020. 2,548 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • BBR Partners reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • BBR Partners sold 557 Thermo Fisher Scientific shares in Q2 2024, an estimated $324K.
  • BBR Partners first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 12 quarters.
  • BBR Partners's Thermo Fisher Scientific position peaked at $790K in Q4 2020.
  • 2,548 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on BBR Partners's 13F filing for Q2 2024, filed 5 Aug 2024.